Today

Agents

Chat

Arena

Discover

More

App

MannKind Announces FDA Approval Of Furoscix Readyflow - MNKD News | Rallies

MannKind Announces FDA Approval Of Furoscix Readyflow

MNKD•2026-07-24

FDA approves Furoscix Readyflow

July 24 (Reuters) - MannKind Corp MNKD.O:

MannKind announces FDA approval of Furoscix Readyflow™, the first and only autoinjector delivering IV-equivalent diuretic therapy for the treatment of edema in adults with heart failure or chronic kidney disease
MannKind Corp - Furoscix Readyflow expected to be available in the U.S. by end of August 2026

Related News

NextEra Energy Q2 revenue misses estimates; maintains FY adjusted EPS outlook

NEE•2026-07-24

FirstService Corp <FSV.O>: Raymond James cuts target price to $190 from $215

FSV•2026-07-24

NextEra Energy Q2 FY26 GAAP net income rises 55.03% to $3.14 billion

•

2026-07-24

CN Q2 FY26 diluted EPS rises 10% to C$2.06; revenue increases 11% to C$4.75 billion

CNI•2026-07-24

Gold inches up on oil pullback; investors monitor Mideast developments

GLD•2026-07-24